Kimura S, Nagoya T, Aoki N
Tokyo Research Institute, Kowa Ltd.
J Biochem. 1989 Mar;105(3):478-83. doi: 10.1093/oxfordjournals.jbchem.a122690.
Four monoclonal antibodies to human thrombomodulin were characterized. Binding of two of these antibodies was dependent on the presence of calcium ions, and approximately 5 mM calcium was required for their maximum binding. These two antibodies inhibited the binding of thrombin to thrombomodulin, thereby inhibiting activation of protein C catalyzed by thrombin-thrombomodulin complex. These two antibodies bind to a major active fragment formed by limited proteolytic digestions of thrombomodulin with elastase and trypsin, suggesting that the antibodies bind to the thrombin-binding site (or its vicinity) located in the epidermal growth factor (EGF)-homology domain. One of the other calcium-independent antibodies also inhibited the binding of thrombin and the activation of protein C, but the inhibition was very weak and was observed only when the antibody was present in a molar excess over thrombomodulin. This antibody did not bind to the protease digests of thrombomodulin. Another calcium-independent antibody did not inhibit either thrombin binding or protein C activation, but bound to the active fragment of protease digests, suggesting that the antibody binds to a region other than the thrombin-binding site in the EGF-homology domain. These observations suggest that thrombomodulin undergoes a calcium-dependent conformational change which may occur in proximity to a thrombin-binding site located in the EGF-homology domain.
对四种抗人血栓调节蛋白单克隆抗体进行了特性鉴定。其中两种抗体的结合依赖于钙离子的存在,最大结合需要约5 mM的钙离子。这两种抗体抑制凝血酶与血栓调节蛋白的结合,从而抑制凝血酶 - 血栓调节蛋白复合物催化的蛋白C活化。这两种抗体与用弹性蛋白酶和胰蛋白酶对血栓调节蛋白进行有限蛋白水解消化形成的主要活性片段结合,表明这些抗体与位于表皮生长因子(EGF)同源结构域中的凝血酶结合位点(或其附近)结合。另一种不依赖钙离子的抗体之一也抑制凝血酶结合和蛋白C活化,但抑制作用非常弱,并且仅当抗体的摩尔量超过血栓调节蛋白时才观察到。该抗体不与血栓调节蛋白的蛋白酶消化产物结合。另一种不依赖钙离子的抗体既不抑制凝血酶结合也不抑制蛋白C活化,但与蛋白酶消化的活性片段结合,表明该抗体与EGF同源结构域中凝血酶结合位点以外的区域结合。这些观察结果表明,血栓调节蛋白经历了依赖钙离子的构象变化,这种变化可能发生在EGF同源结构域中的凝血酶结合位点附近。